department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Litfulo · pharmadog

pharmadog
drugs
Litfulo

drug

patient view →

ritlecitinib

Marketedupdated 2mo ago

by $PFE PFIZER INC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Litfulo

generic

ritlecitinib [INN]

indication

Alopecia Areata

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Jun 23, 2028

~2.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Oct 17, 2041compositionUS 12116368
Dec 3, 2034method-of-use (U-3994)US 12077533
Dec 3, 2034compositionUS 9617258

FDA exclusivities (1)

Jun 23, 2028NCENew Chemical Entity (5y)2.0y

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying ritlecitinib

phase2A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.recruitingn=240
phase2A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.recruitingn=200
—A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settingscompletedn=123
—Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinibrecruitingn=850
phase2Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)active not recruitingn=78
—A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.recruitingn=3,000
—Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USactive not recruitingn=300
phase3A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areataactive not recruitingn=550

more trials →